Please be mindful of important information for patients who suffer from Psoriasis who may have used, or are currently using, the drug Raptiva. There have been recent announcements indicating that Genentech will be voluntarily withdrawing this drug from the U.S. market due to the risk of PML, which has potentially fatal implications.
If you are taking this medication, be certain to contact your healthcare professional for alternative solutions. Always be willing to have an open and honest dialogue with your physician regarding any concerns that you may have. Rest assured, there are many solutions to the treatment of Psoriasis.
Consult your health care team or contact us at the Center For Dermatology, Laser and Cosmetic Surgery for an appointment to discuss your care.
Offices are conveniently located at Moss Plaza -9892 Bustleton Avenue in Northeast Philadelphia or 822 Montgomery Avenue, Ste 100, in Narberth, PA. Call 215-676-2464 to speak to one of our dedicated professionals.